Investment Stage

Focus Areas

About Investor

James Lousararian is a Managing Director at BioVentures MedTech Funds. The firm invests in emerging and growth-stage MedTech, and its funds target $5–10MM (Innovation Fund) and $10–25MM (Growth Capital Fund) per investment, typically deployed across tranches as companies de-risk and scale. His work background is heavily operator-leaning: BioVentures notes 20+ years as a life-sciences and healthcare entrepreneur, including co-founding and/or serving as CEO of multiple startups (with several exits) and continuing as CEO of Verax Biomedical. He also held senior roles earlier in his career at Thermo Electron/Thermo ReTec and began as a lawyer before moving deeper into company-building.